Muscle loss (muscle atrophy) in our dogs can occur for a variety of different reasons.
Because of the fast-paced nature of the sport we participate in, injuries are not uncommon. Sometimes it's a mild injury that requires a short rest and sometimes surgery is required. More than just missing out on training and competing, being sidelined by an injury can cause muscle loss. A dog that is limping is not using his limb so the muscles are not being used for normal movement, resulting in atrophy. If extended rest or limited activity is required to heal, muscle atrophy will occur over time.
As our retired agility dogs age, they experience a form of age-related muscle loss known as sarcopenia. Sarcopenia is the leading cause of frailty, which can result in a reduced life span in dogs (Hua, Julie, et al. "Assessment of frailty in aged dogs." American journal of veterinary research 77.12 (2016): 1357-1365). Quadriceps muscle loss puts dogs at an increased risk for developing canine osteoarthritis due to the increased strain that is placed on the joints, leading to cartilage degradation.
Produced from fertilized egg yolk using a proprietary, low temperature manufacturing process, Fortetropin® is a proprietary advanced nutrition product that has been shown in numerous veterinary and human clinical studies to build muscle and reduce muscle loss due to aging or injury. Dr. Padliya will share some of the data from the studies and there are PDFs of the actual study publications in the classroom. He will also discuss methods for assessing muscle strength such as the muscle condition score, the 6-minute walk test, and canine manual muscle testing.
An all-natural, nutrition product, Fortetropin supplementation is a safe and promising strategy to address canine muscle health and thus help agility dogs achieve peak levels of performance.
How do I access the webinar?
There is no charge for this presentation, but you will have to complete the checkout process and pay for any other items you order. After you finish checking out, you will receive 2 email confirmations: the first is a receipt acknowledging that your order has been received and the second email contains the link for your Clean Run Learning Center program. Just click on the link in the email to complete enrollment. If you already have a Learning Center account, then you will go directly to your educational program. If you do not, then you will enter your email address and a password to use for this Learning Center program and any future ones your purchase. Please be aware that this is a separate account you are establishing on https://cleanrunonline.com/home and it is not the same as your Clean Run website account (although you can use the same email and password for both accounts).
If you have a Clean Run website account, then you can also access your program at anytime by signing in at cleanrun.com and selecting Classes/Webinars from the My Account menu.
Dr. Neerav Dilip Padliya has served as Vice President, R&D at MYOS Corporation since 2013 during which time he has managed human and veterinary clinical programs in addition to preclinical studies with leading universities and CROs to study the impact of nutrition products on sarcopenia, muscle disuse atrophy and cancer cachexia in humans and animals. He provides scientific oversight to MYOS' Animal Health Business, working closely with leading Veterinarians and Veterinary Researchers across the United States to leverage the extensive research behind the advanced nutrition product, Fortetropin®.
The AAVSB RACE-Approved Veterinary Continuing Education (CE) Courses that Dr. Padliya has developed and taught have been completed by Veterinarians that hail from 50 nations including the United States, Canada, Mexico, Brazil, United Kingdom, France, Germany, Italy, Switzerland, Belgium, Israel, China, Japan, South Korea, Vietnam, Australia and South Africa and that represent leading Colleges of Veterinary Medicine in addition to some of the world’s largest Pet Food and Animal Health Companies. Since Dr. Padliya launched MYOS’ CE Program in June 2020, >2,100 RACE Certificates of Completion have been issued.
Prior to joining MYOS, Dr. Padliya was a Sr. Applications Scientist at SCIEX/Danaher where he worked closely with Scientists in the Biotechnology, Pharmaceutical and CRO sectors to solve challenging problems related to protein characterization and systems biology. At Celgene/Bristol-Myers Squibb, Dr. Padliya established a state-of-the art Proteomics Laboratory to conduct basic research on Placental Stem Cells and Natural Killer Cells. Dr. Padliya graduated with a Ph.D. in Analytical Chemistry from the State University of New York at Buffalo and has co-authored 7 peer-reviewed publications and is a co-inventor on 8 U.S. and European Patents. He completed a Postdoctoral Fellowship at the U.S. Department of Agriculture, Beltsville, Maryland.